Drugs / Botulinum Neurotoxin Serotype E
Botulinum Neurotoxin Serotype E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03429556 | May → Jul 2018 | — | Allergan | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Botulinum Neurotoxin Serotype E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03429556 ↗ |
| Modality | Protein / enzyme biologic | “Biological: Botulinum Neurotoxin Serotype E” NCT03429556 ↗ |